Research Topics
Species | Alan A ArslanSummaryAffiliation: New York University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)Alan A Arslan
Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Ave, TH 528, New York, NY 10016, USA
Arch Intern Med 170:791-802. 2010..Obesity has been proposed as a risk factor for pancreatic cancer...
Reproducibility of serum pituitary hormones in womenAlan A Arslan
Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NBV 9E2, New York, NY 10016, USA
Cancer Epidemiol Biomarkers Prev 17:1880-3. 2008....- Factors associated with inflammation markers, a cross-sectional analysisTess V Clendenen
Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
Cytokine 56:769-78. 2011..Our findings suggest that risk factors for chronic diseases (age, BMI, menopausal status, parity, NSAID use, family history of breast and ovarian cancer, and smoking) are associated with inflammation markers in healthy women... - Premenopausal serum androgens and breast cancer risk: a nested case-control studyAnne Zeleniuch-Jacquotte
Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016, USA
Breast Cancer Res 14:R32. 2012..Prospective epidemiologic studies have consistently shown that levels of circulating androgens in postmenopausal women are positively associated with breast cancer risk. However, data in premenopausal women are limited... - Circulating prolactin levels and risk of epithelial ovarian cancerTess V Clendenen
Department of Population Health, New York University School of Medicine, New York, NY, USA
Cancer Causes Control 24:741-8. 2013..Indirect evidence from experimental and epidemiological studies suggests that prolactin may be involved in ovarian cancer development. However, the relationship between circulating prolactin levels and risk of ovarian cancer is unknown... - Endogenous hormones and coronary heart disease in postmenopausal womenYu Chen
Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016 3240, United States
Atherosclerosis 216:414-9. 2011..These findings suggest that circulating estradiol and SHBG are not associated with CHD risk in postmenopausal women beyond what can be explained by the variation in hypertension status, BMI, and cholesterol... - Circulating inflammation markers and risk of epithelial ovarian cancerTess V Clendenen
Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
Cancer Epidemiol Biomarkers Prev 20:799-810. 2011..The purpose of this study was to assess the association between circulating levels of inflammation mediators and subsequent risk of ovarian cancer... - Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective studyYian Gu
Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016 3240, USA
Cancer Causes Control 21:1323-33. 2010..This study suggests that dysregulated cytokines may be involved in B-NHL development... - Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersAnne Zeleniuch-Jacquotte
Department of Environmental Medicine and Cancer Institute, New York University, New York, 10016 3240, USA
Am J Epidemiol 172:36-46. 2010.... - Temporal reliability of cytokines and growth factors in EDTA plasmaTess V Clendenen
Department of Environmental Medicine, New York University Langone Medical Center, New York, NY, USA
BMC Res Notes 3:302. 2010..Cytokines are involved in the development of chronic diseases, including cancer. It is important to evaluate the temporal reproducibility of cytokines in plasma prior to conducting epidemiologic studies utilizing these markers... - Reproducibility of serum cytokines and growth factorsYian Gu
Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016, USA
Cytokine 45:44-9. 2009..Such an assumption is rarely tested although it may not be valid for all biomarkers. The objective of this study was to investigate the temporal reproducibility of a panel of cytokines and growth factors... - Maternal and neonatal outcomes in early glucose tolerance testing in an obstetric population in New York cityOrli Langer Most
New York University Medical Center, New York, NY, USA
J Perinat Med 37:114-7. 2009..We sought to compare pregnancy outcomes in women who were diagnosed with GDM early in pregnancy with those diagnosed at the standard 24-28 weeks' gestation... - Characterization of a genomic signature of pregnancy identified in the breastIlana Belitskaya-Levy
Division of Biostatistics, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
Cancer Prev Res (Phila) 4:1457-64. 2011..The genomic signature of pregnancy could be used as an intermediate marker to assess potential chemopreventive interventions with hormones mimicking the effects of pregnancy for prevention of breast cancer... - Parallel maternal and fetal immune activation by bacterial toxins in vitroBruce K Young
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA
J Perinat Med 40:73-6. 2011..A maternal blood panel test might serve as a diagnostic screen for subclinical infection in patients at risk for preterm labor... - Atypical ezrin localization as a marker of locally advanced breast cancerAlan A Arslan
Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA
Breast Cancer Res Treat 134:981-8. 2012..The cytoplasmic relocalization of ezrin may therefore represent a novel marker for large malignant tumor size, reflecting the unique biology of LABC... - The diagnosis, treatment, and follow-up of cesarean scar pregnancyIlan E Timor-Tritsch
Department of Obstetrics and Gynecology, NYU School of Medicine, New York, NY 10016, USA
Am J Obstet Gynecol 207:44.e1-13. 2012..The diagnosis and treatment of cesarean scar pregnancy (CSP) is challenging. The objective of this study was to evaluate the diagnostic method, treatments, and long-term follow-up of CSP... - Predictors of severe perineal lacerations in Chinese womenNadav Schwartz
Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA
J Perinat Med 37:109-13. 2009..We sought to test the hypothesis that this risk is related to body mass index (BMI) or to a relative fetal-maternal size disproportion as measured by the ratio of the newborn birthweight to maternal BMI (BW:BMI)... - Postmenopausal levels of endogenous sex hormones and risk of colorectal cancerTess V Clendenen
Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
Cancer Epidemiol Biomarkers Prev 18:275-81. 2009..Our results suggest that endogenous estrone is associated with increased risk of colorectal cancer in postmenopausal women... - Debate preparation/participation: an active, effective learning toolNikki Koklanaris
Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York, USA
Teach Learn Med 20:235-8. 2008..Passive educational techniques (such as lectures) are thought to be less productive than active learning...